The phospholipid analogue, hexadecylphosphocholine, inhibits protein kinase C in vitro and antagonises phorbol ester-stimulated cell proliferation
- 31 December 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (12), 1650-1653
- https://doi.org/10.1016/0277-5379(91)90438-j
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Protein kinase C in transmembrane signallingFEBS Letters, 1990
- Protein kinase C inhibition by calmodulin and its fragmentsProtein Journal, 1990
- Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)European Journal of Cancer and Clinical Oncology, 1988
- Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction.Journal of Biological Chemistry, 1988
- Hexadecylphosphocholine (D 18506) in the Topical Treatment of Skin Metastases: A Phase-I TrialOncology Research and Treatment, 1988
- Distribution and metabolism of hexadecylphosphocholine in miceLipids, 1987
- Modulation of chemical carcinogenesis in rats by alkyl lysophospholipidsLipids, 1987
- Alkyl phosphocholines: Toxicity and anticancer propertiesLipids, 1987
- Determination of cell number in monolayer culturesAnalytical Biochemistry, 1986
- Inhibition of the growth of human lung cancer cells by alkyl-lysophospholipid analogsCancer Letters, 1986